Jeff Weinberger is a partner in the Los Angeles firm of Munger, Tolles & Olson. Mr. Weinberger's practice consists principally of antitrust and intellectual property litigation in trial and appellate courts. He has been lead counsel in a number of landmark private and government antitrust cases and patent cases. He has extensive court and jury trial experience, having tried antitrust, patent and other complex business cases for both corporate defendants and corporate plaintiffs in state and federal courts. In addition, he has argued numerous appeals before the Ninth Circuit Court of Appeals, the Court of Appeals for the Federal Circuit, and other federal appellate courts. Most recently, Mr. Weinberger argued before the United States Supreme Court on behalf of respondents in a closely watched case at the intersection of antitrust and patent law regarding pharmaceutical patent settlements.
Mr. Weinberger is a past Chair of the Section of Antitrust and Unfair Competition Law, State Bar of California, and a past President of the Association of Business Trial Lawyers of Southern California. He has served as Program Chair for the State Bar Antitrust and Unfair Competition Section's annual Golden State Antitrust Institute, and the Association of Business Trial Lawyer's Annual Seminar. He has lectured on numerous panels, including CEB's annual Federal Practice Institute, the ABTL's Judicial College, the Golden State Institute Antitrust Seminar, the Conference Board Annual Antitrust Seminar, and the California State Court Appellate Judge's Conference, and the USC Intellectual Property Law Institute. He has been named in Best Lawyers of America, and as a Southern California Super Lawyer in the practice area of Antitrust Litigation, for a number of years. In 2011, he was recognized as a BTI Client Service All Star for outstanding client service, outstanding results and legal skills. Mr. Weinberger has been ranked repeatedly as a leading antitrust litigator by Chambers USA. He has also been recognized by LMG Life Sciences as a life science star for litigation involving drug formulation and generic drugs.